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Edited by Gianni CesareniAbstract Myocyte enhancer factor (MEF2) are MADS box
transcription factors that play important roles in the regulation
of myogenesis and morphogenesis of muscle cells. MEF2 pro-
teins are activated by mechanical overload in the heart. In this
study, we found the interaction of MEF2C with the regulatory
protein Ki-1/57 using yeast two-hybrid system. This interaction
was conﬁrmed by GST-pull down assay in vitro and by co-immu-
noprecipitation in vivo. This interaction is also dependent on
pressure overload in the heart. Co-imunoprecipitation assay with
anti-MEF2 and anti-Ki-1/57 antibodies demonstrated a basal
association between these proteins in the left ventricles of control
rats. Pressure overload caused a reduction in this association.
Ki-1/57 co-localizes with MEF2 in the nucleus of myocytes of
control rats. However, after submitting the animals to pressure
overload Ki-1/57 leaves the nucleus thereby decreasing this
co-localization. Ki-1/57 also exerts an inhibitory eﬀect upon
MEF2C DNA binding activity. These results suggest that Ki-
1/57 is a new interacting partner of MEF2 protein and may be
involved in the regulation of MEF2 at the onset of hypertrophy.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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hypertrophy1. Introduction
The enlargement of the heart during hypertrophy involves
an increase in size and mass of individual cardiac myocytes.
This implies a quantitative upregulation of the vast majority
of the genes in the cell, a process that is controlled by complex
transcriptional events activated by posttranslational activation
of a set of transcription factors [1]. The initial response to
hypertrophic stimuli include a coordinated rapid and transientAbbreviations: TAoC, transverse aortic constriction; LV, left ventricle;
h, human; r, rat; m, mouse; rMEF2C, MEF2C from rat; YTS, yeast
two-hybrid system
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doi:10.1016/j.febslet.2005.03.078activation of immediate-early genes like c-fos, c-jun and c-myc
[2] followed by the activation of fetal genes such as a-skeletal-
actin, b-MHC, and atrial natriuretic peptide [3] and a time-
dependent increase in protein synthesis.
Accumulating data have suggested the signiﬁcant role of the
MEF2 family of transcription factors in the hypertrophic
growth of the myocardium. The myocyte enhancer factor 2
(MEF2) family belongs to the MADS-box class of transcrip-
tion factors and plays multiple roles in muscle cells to control
myogenesis and morphogenesis. There are four genes in the
mef2 family: A, B, C and D. The MEF2 proteins present
two N-terminal conserved domains: the MADS box and the
MEF domain that are involved in DNA binding and dimeriza-
tion whereas the C-terminal regions of MEF2 proteins are re-
quired for transcriptional activation [4]. MEF2 proteins bind
the A/T-rich DNA consensus sequence (C/T)TA(A/T)4TA(G/
A), as homo- and heterodimers [5]. MEF2 transcription factors
regulate many skeletal and cardiac muscle proteins like a-myo-
sin heavy chain and troponins [4]. The MEF2 proteins are
widely expressed, unlike MEF2C whose transcripts are re-
stricted to muscle, brain, and spleen [6]. MEF2C is necessary
for proper development of the murine heart and vasculature
[7] and is up-regulated by the C-terminus of myogenin [8].
Recently, MEF2 regulation has been broadly explored.
MEF2 is constitutively bound to its cognate DNA-binding ele-
ments in the nucleus in inactivated cells. MEF2 recruits a fam-
ily of functionally redundant transcriptional repressors
including Cabin1 (also known as Cain) [9], MEF2 interacting
transcriptional repressor (MITR) [10,11], and HDAC-4, -5
[12]. These MEF2-speciﬁc co-repressors recruit histone deacet-
ylases to MEF2-associated promoter region, which remodel
the chromatin structure, thereby silencing the promoter activ-
ity. Upon calcium inﬂux, these MEF2 repressors are removed
from MEF2 by activated calmodulin. This enables it to bind to
such co activators as p300, leading to transcription and activa-
tion of the target genes [13]. Cabin1 was recently identiﬁed as a
transcriptional repressor of MEF2, which can be released from
MEF2 in a calcium-dependent fashion [14].
The MEF2 transcription factors serve as targets for hyper-
trophic signaling [12,15]. In the normal adult myocardium,
MEF2 exhibits only basal activity, which is likely to be re-
quired for maintenance of contractile protein gene expression
and energy metabolism [16,17]. We have shown that the rapid
activation of MEF2 by hypertrophic stimuli plays a centralblished by Elsevier B.V. All rights reserved.
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gene c-jun [15], suggesting that it may play a central role to
the regulation of early gene expression induced by hypertro-
phic stimuli.
In order to identify new proteins that interact with MEF2
proteins and may regulate MEF2 activity in the heart when in-
duced by mechanical overload before the onset of hypertro-
phy, we used a yeast-two hybrid assay with a MEF2C
deletion as bait to screen a cDNA library of rat left ventricle
previously induced by 6 h of transverse aortic constriction
(TAoC). We found that MEF2C interacts with the novel pro-
tein Ki-1/57, which exerts an inhibitory eﬀect on MEF2C
DNA binding activity. We tested the eﬀect of mechanical over-
load on the interaction between MEF2 and Ki-1/57 and found
that the association of these two proteins decreases in rat heart
submitted to TAoC.
Our data suggest that Ki-1/57 might be a negative regulator
of MEF2 and that the interaction between the two proteins is
subjected to physiological regulation in the heart.2. Materials and methods
2.1. Plasmids constructions
RNA was extracted from left ventricle of male Wistar rats with Tri-
zol Reagent (Gibco-BRL) according to the manufacturers instruc-
tions. 1 lg of total RNA was used for First Strand cDNA synthesis
with oligo(dT) and reverse transcriptase Superscript II (Gibco-BRL)
following manufacturers protocol.
rMEF2C was isolated from rat heart by RT-PCR using a set of oli-
gonucleotides designed based on the MEF2C murine sequence (Acces-
sion No. NM_025282 – NCBI Database) because rat MEF2C
sequences were not available. The PCR products encoding diﬀerent
fragments of MEF2C were then cloned into pBTM116 and sequenced.
The rMEF2C deletion mutants were co-transformed into yeast strain
L40 with the empty vector pGADT7-rec (Clontech) used to construct
the cDNA library.
2.2. Construction of a rat left ventricle cDNA library
A rat left ventricle (LV) cDNA library was constructed using the
Matchmaker Library Construction and Screening Kit (Clontech) by
recombination in yeast strain L40. 2 lg RNA of rat LV that had been
submitted to 6-h pressure overload was used for cDNA synthesis
according to the manufacturers instructions. First strand cDNA was
ampliﬁed by Long Distance PCR using the Advantage2 PCR Kit
(Clontech). The puriﬁed library cDNA was then fused to the GAL4
activation domain of pGADT7-rec (Clontech) expressing vector by
recombination in L40 yeast strain.
2.3. Yeast two-hybrid screening
The pBTM-MEF2C(1–169) bait construction expresses a fragment
spanning the N-terminal of MEF2C protein including MADS box
and MEF2 domains fused to the LexA DNA binding domain pres-
ent in the pBTM116 vector. The rat LV cDNA library in L40 yeast
cells was ampliﬁed and cells were co-transformed with pBTM-
MEF2C(1–169) according to the protocol supplied by Clontech.
The screening was carried out on minimal medium plates without
tryptophan, leucine and histidine and containing 10 mM 3-amino-
2,4 triazole.
b-Galactosidase activity in yeast cells was measured by the ﬁlter as-
say method. Yeast transformants (Leu+, Trp+, His+) were transferred
onto nylon membranes, permeabilized in liquid nitrogen, and placed
on Whatman 3MM paper previously soaked in Z buﬀer (60 mM
Na2HPO4, 40 mM NaH2PO4, pH 7.0, 10 mM MgCl2, and 50 mM 2-
mercaptoethanol) containing 1 mg/ml 5-bromo-4-chloro-3-indolyl-b-
D-galactoside. After incubation at 37 C for 30 min to 2 h, the yeast
cells forming dark blue colonies were taken from replica plates for fur-
ther analysis. Plasmids from positive clones were isolated and their
DNA sequenced.DNA sequences obtained were translated into amino acid sequences
by the ORF Finder and submitted to BLAST and Clustal W found in
the NCBI Database (http://www.ncbi.nlm.nih.gov/).
2.4. Protein expression and puriﬁcation
A cDNA coding for rat MEFC2(1–169) from the pBTM-MEF2C(1–
169) construction was sub cloned as a fusion to GST into pGEX5x-2
(Amersham). This new construction was called pGEX-MEF2C(1–
169). 6xHis-hKi-1/57 was constructed by sub cloning the cDNA encod-
ing full length human Ki-1/57 (1–413) [18] into pET28a.
GST and GST-rMEF2C(1–169) proteins were expressed in Esche-
richia coli BL-21(RIL) Codon Plus by induction with 0.5 mM IPTG
at 30 C for 4 h. GST-hKi-1/57 expression was induced with 1 mM
IPTG at 37 C for 4 h. 6xHis-hKi-1/57 was induced with 1 mM IPTG
at 37 C for 6 h.
Bacteria were harvested by centrifugation at 10 000 · g for 20 min
and lysed by the addition of 5 mg lysozyme in HNE Buﬀer plus pho-
phatase and protease inhibitors (25 mM HEPES, 150 mM NaCl,
1 mM EDTA, 1% Triton X-100, 10 mM NaH2PO4, 10 mM NaF,
10 mM Na3VO4, 2 mM PMSF, and 0.1 mg of aprotinin/ml), incuba-
tion for 20 min at 4 C followed by three freeze–thaw cycles plus son-
ication. After centrifugation at 14.000 · g for 20 min, supernatants
containing GST-fused proteins were incubated with Glutathione–Se-
pharose 4B (Amersham Pharmacia Biotech) at 4 for 2 h. Sepharose
beads were then washed four times with HNE buﬀer plus phosphatase
and protease inhibitors and 1% Triton X-100. After the last wash,
beads were frozen in a solution containing HNE buﬀer plus phopha-
tase and protease inhibitors and 50% glycerol and stored at 80 C.
The supernatant containing h6xHis-Ki-1/57 was applied to a Ni-
NTA column (Qiagen). Column washing and elution were performed
according to the manufacturers instructions.
2.5. In vitro binding assay, Western blot analysis and antibodies
GST and rGST-MEFC(1–169) conjugated to Glutathione–Sephar-
ose beads were separately incubated with fusion protein 6xHis-hKi-
1/57 in a ﬁnal volume of 500 ll binding buﬀer (100 mM NaCl, 2 mM
EDTA, 5% Glycerol, 0.5% Triton X-100 and 1 mM PMSF) for 3 h
at 4 C. After incubation, beads were washed three times with binding
buﬀer and boiled with Laemmli sample buﬀer. Proteins were then re-
solved in 10% SDS–polyacrylamide gel electrophoresis and transferred
to nitrocellulose membranes for Western blot analysis. One protein gel
was not transferred, but dyed with Coomassie blue for visualizing pro-
tein input. Membranes were blocked with 3% non-fat milk for 1 h,
washed and incubated with primary monoclonal antibodies A26
anti-Ki-1/57 [19] or anti-GST [20] overnight. The anti-Ki-1/57 mono-
clonal antibody A26 detects both the human and murine proteins
(rat and mouse) [19]. After incubation, membranes were washed
and incubated with 2 lCi [I125] labeled protein A for 2 h at room
temperature. [I125]protein A bound to antibodies was detected by auto-
radiography.
2.6. Heart extracts and co-immunoprecipitation
Experiments were performed with male Wistar rats (160–200 g) that
underwent acute pressure overload (1–6 h) induced by TAoC. After
the end of TAoC periods, rat left ventricles were removed for prepara-
tion of heart extracts as previously described [21]. Brieﬂy, rat left ven-
tricles were homogenized in 10 volumes of solubilization buﬀer (1%
Triton X-100, 100 mM Tris–Cl, pH 7.4, 100 mM NaH2PO4, 100 mM
NaF, 10 mM EDTA, 10 mM Na3VO4, 2 mM PMSF, and 0.1 mg/ml
aprotinin) at 4 C. The extracts were centrifuged at 8000 · g at 4 C
for 20 min, and the supernatant was used for the assays. Protein con-
centration was determined by the Bradford dye binding method.
For the co-immunoprecipitation experiments, 5 mg of heart extracts
were incubated with 20 lg of antibody anti-MEF2 C-21 (Santa Cruz)
at 4 C overnight. Protein A – Sepharose (Amersham) was added to
the extracts followed by two more hours of incubation at 4 C. After
incubation, Protein A – sepharose beads were washed three times with
washing buﬀer (100 mM Tris–Cl, pH 7.5, 1 mM EDTA, 2 mM
Na3VO4 and 0.5% Triton X-100). The samples were then resuspended
in Laemmli sample buﬀer and heated for 5 min at 100 C. Proteins
were separated on SDS–PAGE and transferred to nitrocellulose
membranes. Membranes were incubated with speciﬁc monoclonal
anti-Ki-1/57 antibody A26 and radioactively marked with [I125] Protein
A. Speciﬁc antibodies were detected by autoradiography.
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The following synthetic oligonucleotides were designed: MEF2S: 5 0-
GTGTTGATCGCTCTAAAAATAACCCTGTCG-3 0 MEF2AS: 5 0-
GTTGGCGACAGGGTTATTTTTAGAGCGATC-3 0 for the MEF2
DNA probe (MEF2 consensus sequence underlined). The oligonucleo-
tides were annealed and labeled with [a-32P] dATP by ﬁll in reaction
with Klenow Polymerase (Promega). 1 lg of GST-rMEFC(1–169)
was incubated with GST-hKi-1/57, 6xHis-hKi-1/57 or 6xHis-hRACK
in a 20 ll ﬁnal volume in binding buﬀer (10 mM Tris–Cl, pH 7.5,
50 mM NaCl, 1 mM EDTA, 1 mM DTT, 2% glycerol, 2% Ficoll,
1 lg BSA and 1 lg de Poly[dI-dC]) plus 20 fmol of MEF2 probe
(5000–10 000 cpm) at room temperature for 20 min. For competition
assays, a 100-fold molar excess of unlabeled MEF2 probe or of a
scrambled DNA probe were incubated with GST-rMEF2C(1–169).
For super shift assay, 2 lg of anti-MEF2 antibody were added to
GST-rMEF2C(1–169) 1 h prior to the binding reaction. Samples were
then submitted to electrophoresis on a non-denaturing 5% polyacryl-
amide gel and run at 300 V for 2 h at 4 C. Gel was dried and exposed
on a ﬁlm and the bands were visualized by autoradiography.
2.8. Immunolocalization by confocal microscopy
Adult rat ventricular myocytes isolation: cardiac myocytes were iso-
lated from left ventricle of adult Wistar rats at 160–180 g by collage-
nase (type IA from Sigma) digestion using a modiﬁed Langendorﬀ
perfusion according to methods previously described [22]. After isola-
tion, ventricular myocytes were immediately transferred to poly-L-ly-
sine coated glass slides and then processed for immunohistochemistry.
Immunoﬂuorescence study: the freshly isolated cardiac myocytes
were ﬁxed (8% paraformaldehyde in PBS, pH 7.4) and blocked with
5% non-fat milk in PBS. The sections of isolated cardiac myocytes
were incubated with primary anti-MEF2 (rabbit) or anti-Ki-1/57
(mouse) antibodies in 1% non-fat milk in PBS overnight at 4 C, fol-
lowed by incubation with anti-rabbit 488 Alexa conjugated secondary
antibody (green) and anti-mouse 568 Alexa conjugated secondary
antibody (red) then mounted in Vectashield (Vector Labs. Inc., Burlin-
game, CA). Immunoﬂuorescence was detected by confocal laser scan-
ning microscopy (Carl Zeiss, Inc.). Double-stained images from
Alexa488 and Alexa568 were acquired by multitracking scanning of
the ﬂuorescence imaging with bandpass emission ﬁlter BP505–550
for Alexa488 and longpass emission ﬁlter LP585 for Alexa568. Dou-
ble-stained images from Alexa488 and Alexa568 channels were simul-
taneously acquired from the same area and superimposed. As negative
controls, cells were not incubated with primary antibodies. No speciﬁc
staining was observed in the negative control.
2.9. Subcellular fractionation
Subcellular fractionation was performed essentially as described in
[15]. Brieﬂy, frozen hearts were minced and homogenized in two vol-
umes of STE buﬀer (0.32 M sucrose, 10 mM Tris–Cl, pH 7.4, 1 mM
EGTA, 2 mM EDTA, 5 mM NaN3, 10 mM 2-mercaptoethanol,
0.2 mM PMSF, 50 mM NaF, and 1 mM Na3VO4) in a polytron
homogenizer. The homogenates were mixed with two volumes of
STE buﬀer and centrifuged (1000 · g, 10 min) to obtain pellets. The
pellet was washed once and suspended in STE buﬀer (nuclear fraction).
The supernatant was centrifuged (100 000 · g, 60 min) to obtain the
cytosol fraction and the pellet, which was then suspended in STE buﬀer
(membrane fraction).
The nuclear fraction was solubilized in Triton buﬀer (1% Triton X-
100, 150 mM NaCl, 10 mM Tris–Cl, pH 7.4, 1 mM EGTA, 1 mM
EDTA, 2 mM Na3VO4, 0.2 mM PMSF, and 50 mM NaF). The frac-
tion was centrifuged (15 000 · g, 30 min, 4 C), and the supernatant
(nuclear fraction) was stored at 80 C.3. Results
3.1. Construction of a non-transactivating deletion mutant of
rMEF2C
DNA sequences coding for transcription factors may trans-
activate the yeast two-hybrid system (YTS) even in the absence
of interacting GAL-4 activation domain-prey fusion proteins.
It has been previously reported that the C-terminal DNA bind-ing domain of MEF2 transcription factors may auto-transacti-
vate the YTS [11]. In order to identify MEF2C partners we
initially screened the ability of diverse rat MEF2C cDNA
sequences fused to LEX A DNA binding domain to auto-
transactivate the YTS. Fig. 1A shows the schematic represen-
tation of ﬁve diﬀerent sequences of MEF2C used to screen
YTS for auto-activation. As indicated in Fig. 1B, only MEF2C
mutant deletions pBTM-MEF2C(107–229) and pBTM-
MEF2C(1–169) did not auto-transactivate the reporter gene
LacZ when co-transformed with empty GAL4 activation
domain coding vector pGADT7-rec. Constructions
pBTM-MEF2C(1–432), pBTM-MEF2C(1–357) and pBTM-
MEF2C(107–357) on the other hand, displayed strong auto-
activation when expressed in yeast and were discarded for
the screening of the cDNA library. The mutant pBTM-
MEF2C(107–229) failed to activate the LacZ reporter. Thus,
we used mutant pBTM-MEF2C(1–169) to screen the adult
rat left ventricle cDNA library. Although we used a mouse
MEF2C sequence to design our oligonucleotides, an alignment
of the 169 amino acids of our pBTMEF2C(1–169) construc-
tion cloned from rat cDNA (Fig. 1C) showed 96% identity
to MEF2C from mouse (Accession No. NM_025282).3.2. N-terminal rMEF2C interacts with rKi-1/57 in the yeast
two-hybrid screening
A cDNA library of rat left ventricle that underwent TAoC
was constructed by yeast recombination with pGADT7-rec
vector in yeast strain L40. Each clone had its coding cDNA
C-terminally fused to the GAL4 activation domain. Using
the deletion mutant pBTMEF2C(1–169) as ‘‘bait’’ 1 · 105
transformants were assayed in the library screening and 130
clones were selected on SD-L-W-H + 10 mM 3AT. From 130
transformants, just 90 were positive in the b-galactosidase ﬁlter
assay. 30 clones were further isolated and sequenced. Four of
the isolated clones carried a partial cDNA encoding a rat
homologue of human Ki-1/57 (NP_055097.1) identiﬁed by
BLAST on the NIH internet site. An alignment of the found
Ki-1/57 rat amino acid sequence showed that it represents
90% sequence identity with its human ortholog (Fig. 2D).3.3. The N-terminal of rMEF2C interacts with full length
hKi-1/57 in vitro
A GST pull down assay was performed to conﬁrm the inter-
action between hKi-1/57 (h, human) and rMEF2C (r, rat) in
vitro (Fig. 2). For this purpose human recombinant protein
6xHis-hKi-1/57 was incubated with GST-rMEF2C(1–169) or
GST fusion proteins conjugated on Gluthatione–Sepharose
beads. After washing, 6xHis-hKi-1/57 was retained by GST-
rMEF2C(1–169), but not by GST. This conﬁrms the ability
of rMEF2C(1–169) to speciﬁcally bind to 6xHis-hKi-1/57.3.4. hKi-1/57 decreases rMEF2C DNA binding activity in vitro
In order to evaluate the eﬀect of the inﬂuence of the interac-
tion between MEF2C and Ki-1/57 on the MEF2C DNA bind-
ing activity, we performed an eletrophoretic mobility shift
assay (EMSA). The recombinant protein GST-rMEF2C(1–
169) formed a complex with MEF2-DNA consensus sequence
in vitro, as indicated by the shift shown in lane 2 of Fig. 3. This
was expected because GST-rMEF2C(1–169) mutant contains
both the MADS-box and the MEF2 domain which are respon-
sible for DNA binding and dimerization of MEF2 family of
Fig. 1. Mapping of rMEF2C deletion mutants for auto activation. (A) Schematic representation of mMEF2C. Diﬀerent N- and C-terminal
truncations of rMEF2C were fused in frame to the DNA-binding domain of LexA in yeast expression vector pBTM116. (B) Co-transformation of
deletion mutants and empty library vector pGADT7-rec in yeast. The auto-activation was analyzed by testing for b-galactosidase activity in yeast
cells. (C) Alignment of amino acid sequence of isolated rat MEF2C(1–169) and mouse MEF2C (NCBI Accession No. NP_079558). Diﬀerent amino
acids are written in bold.
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tion of recombinant full length GST-hKi-1/57 reduced the
DNA binding activity of GST-rMEF2C(1–169) indicates a
negative regulation of GST-rMEF2C(1–169) by GST-hKi-1/
57. The speciﬁcity of this inhibition was tested by incubating
GST-rMEF2C(1–169) with the recombinant full-length con-
trol protein 6xHis-hRACK-1. As shown in lane 4 of Fig. 3,
6xHis-hRACK1 did not inﬂuence GST-rMEF2C(1–169)
DNA-binding activity, but the fusion protein 6xHis-hKi-1/
57, caused a reduction in DNA/MEF2 complex, comparable
to that seen with GST-hKi-1/57. The addition of anti-MEF2
antibody to the binding reaction caused a weak supershift.
The results of competition assay with cold MEF2 oligonucleo-
tide and with a cold unrelated oligonucleotide (NF-kB consen-
sus oligonucleotide) further indicated the speciﬁcity of the
binding reaction. We also performed negative controls with
GST, GST-hKi-1/57, 6xHis-hRACK-1 and 6xHis-hKi-1/57.None of these proteins could bind to double stranded MEF2
consensus DNA alone in the conditions of our experiments
(data not shown).
3.5. The interaction between MEF2 and Ki-1/57 is regulated by
mechanical stress
We have previously shown that MEF2 transcription factors
are activated by mechanical overload in left ventricle of rat
heart [16]. Here, we ﬁrst performed western blot and immuno-
histochemistry analysis to characterize the eﬀect of acute pres-
sure overload on Ki-1/57 and MEF2 expression in the left
ventricle and cardiac myocytes of the rat heart. As shown in
Fig. 4A, pressure overload lasting for 6 h did not change the
expression of MEF2 factors recognized by an antibody raised
against MEF2A (which cross-reacts with MEF2C and D).
However, a consistent increase (100%) of a double-band
Ki-1/57, was seen at 3 and lasting up to 6 h after TAoC
Fig. 2. rMEF2C interacts with hKi-1/57 in in vitro Pull down assay of GST-rMEF2C(1–169) with 6xHis-hKi-1/57. GST-rMEF2C(1–169) or GST
protein was conjugated to Gluthatione–Sepharose beads. Beads with conjugated with GST or GST-rMEF2C(1–169) were separately incubated with
6xHis-hKi-1/57. After extensive washing, beads were boiled in Laemmli buﬀer and proteins were resolved in 10% SDS–PAGE and transferred to
nitrocellulose membranes for Western blotting analysis. Membranes were incubated with primary antibodies Monoclonal A26 anti-Ki-1/57 and
monoclonal anti-GST overnight. After incubation with secondary antibodies, membranes were washed and incubated with [I125]protein A. Protein
bands were detected by autoradiography. The ﬁrst 3 lanes of the gel and the Western blot are protein input. The fourth lane represents a pull down
control with GST and the ﬁfth lane a pull down of GST-rMEF2C(1–169) with 6xHis-hKi-1/57. (A) Protein gel dyed with Coomassie blue for
visualizing all proteins. (B) Western blot with antibody anti-Ki-1/57. (C) Western blot with antibody anti-GST. (D) Alignment of the isolated rat Ki-
1/57 and human Ki-1/57 (NCBI NP_055097.1) amino acid sequence. The amino acids in bold represent the diﬀerences between these two sequences.
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antibody and immunoblot with anti-Ki 1/57 demonstrated a
basal association between these proteins in the left ventricles
of control rats. Pressure overload caused a reduction in this
association already detected 1 h after aortic constriction (Fig.
4C). In cardiac myocytes extracted from left ventricles of con-
trol rats, staining with anti-MEF antibody showed a nuclear
localization of MEF2 protein and also a less intense staining
at sarcoplasma (Fig. 5A), where it was regularly distributed
following a sarcomeric pattern of distribution. Staining with
anti-Ki-1/57 antibody showed a nuclear and sarcoplasmic dis-
tribution (Fig. 5B). However, the sarcoplasmic staining was
stronger than the nuclear staining and also followed a sarco-
meric pattern of distribution. Anti-MEF2 and anti-Ki-1/57
antibodies double staining indicated that MEF2 and Ki-1/57
were co-localized in the nuclei of cardiac myocytes but they
were not co-localized in the sarcoplasma (Fig. 5C). Pressure
overload reduced the amount of MEF2 detected in the sarcopl-
asma and the amount of Ki-1/57 in the nucleus, where the co-
localization of both proteins could no longer be detected (Fig.
5D–F).Subcellular fractions of rat hearts from sham-operated and
from those rats that underwent a 6 h TAoC were analyzed
by Western blot with antibody anti-Ki-1/57. As seen in Fig.
5G, Ki-1/57 is present in the cytoplasmic as well as in the nu-
clear fraction of control hearts. However, the amount of Ki-1/
57 decreases signiﬁcantly in the nuclear fraction after TAoC.4. Discussion
In a yeast two-hybrid screen of a rat LV cDNA library
we identiﬁed a cDNA encoding a rat homologue of the
N-terminal of Ki-1/57 protein as a partner of rat MEF2C.
The interaction between MEF2C and Ki-1/57 was found to re-
duce the recombinant MEF2C protein binding to the MEF2
DNA consensus sequence in vitro. In rat left ventricle, this
interaction was rapidly reduced in response to pressure over-
load. These ﬁndings suggest that Ki-1/57 acts upstream of a
MEF2C regulatory pathway involved in transcriptional con-
trol of myocardial gene expression in response to mechanical
stress.
Fig. 3. The interaction of hKi-1/57 with rMEF2C in vitro decreases
rMEF2C DNA binding activity. Eletrophoretic mobility shift assay of
recombinant rat rGST-MEF2C(1–169) protein with radioactively
labeled MEF2 consensus DNA. Lane 1 is a negative control without
protein. Lane 2 shows the complex formation between GST-
rMEF2C(1–169) and the DNA. Lanes 3–8 were added the same
quantity of recombinant GST-rMEF2C(1–169) plus recombinant
proteins (h for human), antibody or DNA as indicated in the ﬁgure.
Fig. 4. rMEF2C associates with rKi-1/57 in vivo and its association is
dependent on mechanical overload in heart. S = Sham operated rats;
1 h, 3 h and 6 h are the time period which rats were submitted to
TAoC. (A) Rat heart control protein extracts or rat heart submitted to
TAoC protein extracts were immunoblotted with antibody anti-
MEF2. (B) Rat heart protein control extracts or submitted to TAoC
were immunoblotted with antibody anti-Ki-157. (C) MEF2 was
immunoprecipitated from rat hearts and immunoblotted with antibody
anti-Ki-1/57.
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1-169 as bait, we found four clones of a partial cDNA encod-
ing a rat homologue of the N-terminal of Ki-1/57 protein
(Accession No. NP_055097.1 – NCBI Database), interactingwith MEF2C. Ki-1/57 is a 57 kDa protein ﬁrst found to be
expressed in Sternberg-Reed cells in Hodgkin lymphoma and
recognized by its cross reactivity with the anti-CD30 antibody
Ki-1 [23,24]. The interaction between rMEF2C and hKi-1/57
was conﬁrmed by means of a pull down assay with GST-
rMEF2C(1–169) fragment and the fusion protein human
6xHis-hKi-1/57, as well as by co-immunoprecipitation assay
with anti-MEF2 and anti-Ki-1/57 antibodies in rat myocardial
extracts. Analysis with diﬀerential centrifugation of rat left
ventricle extracts and immunohistochemistry demonstrated
that both rKi-1/57 and rMEF2 are localized preferentially in
the nuclei of rat myocardial cells, where they co-localize. This
not only extends to cardiac myocytes the previous ﬁnding that
Ki-1/57 is localized in nuclei [18], but also suggests that this
protein may regulate myocardial MEF2 transcriptional
activity. Accordingly, experiments with EMSA showed that
hKi-1/57 reduces the binding activity of the recombinant
GST-rMEF2C (1–169) to the MEF2 DNA consensus se-
quence. Moreover, the demonstration here that mechanical
stress reduced the amount of rKi-1/57 co-immunoprecipitated
with rMEF2, as well as the amount of Ki-1/57 in rat myocar-
dial nuclear extracts, further support a functional meaning for
Ki-1/57 interaction with MEF2 in cardiac myocytes, possibly
as a co-repressor protein partner. Taken together, these data
support the hypothesis that by reducing the binding of Ki-1/
57 to MEF2 and Ki-1/57 translocation from nuclei to sarcopl-
asma, mechanical stress potentially favors an increase of
MEF2-DNA binding activity implying that such interaction
may play a role in the regulation of transcriptional activity
in cardiac myocytes in response to mechanical stress. Indeed,
this agrees with our previous ﬁnding that mechanical stress
rapidly increases in the MEF2-DNA binding activity [15]
and thereby coordinates the transcriptional control of immedi-
ate early genes in rat heart.
Several MEF2 co-repressors, such as Cabin1/Cain and class
II histone deacetylases (HDACs), have been identiﬁed and
demonstrated to be dynamically regulated by signaling path-
ways involved in MEF2 activation. Cabin1 binds to MEF2
through the MADS/MEF2 box (DNA binding domain) and
sequesters MEF2 in a transcriptional inactive state, contribut-
ing to maintain the quiescence of MEF2 in unstimulated cells
[25]. Otherwise, inhibition of MEF2 activity by HDAC4 oc-
curs without interfering in DNA binding activity of MEF2
[26]. Phosphorylation by calcium/calmodulin-dependent
protein kinase (CaMK) has been shown to promote HDAC4
nuclear export to the cytoplasm and the concomitant de-
repression of MEF2 in the nucleus [27]. Our data indicate that
Ki-1/57, unlike HDAC4 but similar to Cabin 1, interacts di-
rectly with MEF2C. Considering that Ki-1/57 interacts with
a fragment of MEF2C containing almost exclusively MADS-
MEF2 box [i.e., MEF2C (1–169) fragment], the inhibition that
Ki-1/57 exerts on MEF2C activity is presumably related to a
direct interference of Ki-1/57 with the ability of MEF2 to bind-
ing DNA.
Although, we presently did not explore potential upstream
regulators of Ki-1/57, previous studies have shown that Ki-1/
57 is a substrate for PKC [18], an enzyme known to be criti-
cally linked to the response of cardiac myocytes to hypertro-
phic inﬂuences. Novel PKC isoforms (e, d, g, and h) have
also been shown to enhance MEF2A transcriptional activity
[28]. Alternatively, Ki-1/57 has also been shown to speciﬁcally
interact with other proteins such as receptor of activated
Fig. 5. Confocal Laser Scanning Microscopy studies showing the immunolocalization of rMEF2 (green) and rKi-1/57 (red) in isolated adult rat
ventricular myocytes. (A) Anti-MEF2 staining in isolated myocytes from control rats. (B) Anti-Ki-1/57 staining of isolated myocytes from control
rats. (C) Anti-MEF2/anti-Ki-1/57 double staining of isolated myocytes from control rats. (D) Anti-MEF2 staining in isolated myocytes from hearts
subjected to TAoC. (E) Anti-Ki-1/57 staining in isolated myocytes from hearts subjected to TAoC. (F) Anti-MEF2/anti-Ki-1/57 double staining in
isolated left ventricular myocytes subjected to TAoC. (G) Western blot of subcellular fractioning with anti-Ki-/57 antibody of rat left ventricle sham
operated and submitted to TAoC. 50 lg of each fraction was loaded in the gel. cyto: Cytoplasmatic fraction; nuc: nuclear fraction; total: whole
protein extract.
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binding domain protein 3 (CHD3) [20], proteins that have
been shown to be potentially involved in the regulation of tran-
scription and chromatin remodeling in diverse cell types. Con-
sidering the critical role played by the various isoforms of PKC
as well as RACK1 [29] in the myocardial hypertrophic growth,
it will be important to determine whether the phosphorylation
of Ki-1/57 by PKC is involved in the regulation of MEF2-Ki-1/
57 interaction.
In conclusion, our present work has shown Ki-1/57 as a novel
protein partner for MEF2C in rat myocardium. The demon-
stration of an in vivo association of MEF2 with Ki-1/57 in
rat myocardium and that the interaction of MEF2C with Ki-1/57 reduces the MEF2C-DNA binding indicates that Ki-1/57
may serve to maintain the quiescence of MEF2 in non-stressed
myocardial cells. Furthermore, the demonstration here that
mechanical stress rapidly reduces the in vivo MEF2/Ki-1/57
association and reduces the amount of Ki-1/57 in the nuclei
of myocardial cells, suggests that the coordinated regulation
of MEF2/Ki-1/57 interaction by upstream signaling mecha-
nisms triggered by mechanical stress might be important for
the regulation of the early transcriptional events in myocardial
cells subjected to hypertrophic conditions. Future studies
should address the regulation of MEF2 by upstream signaling
pathways as well as the outcome of transcriptional regulation
by coordinated MEF2 in concert with Ki-1/57.
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